LEVEL 4 J01DC01

Δραστικές

CEFOXITIN

Φάρμακα

  • DRUGBANK - Cefoxitin
  • indication:

    For the treatment of serious infections caused by susceptible strains microorganisms.

  • pharmacology:

  • mechanism:

    The bactericidal action of cefoxitin results from inhibition of cell wall synthesis.

  • toxicity:

    The acute intravenous LD50 in the adult female mouse and rabbit was about 8.0 g/kg and greater than 1.0 g/kg, respectively. The acute intraperitoneal LD50 in the adult rat was greater than 10.0 g/kg.

  • absorprion:

  • halflife:

    The half-life after an intravenous dose is 41 to 59 minutes.

  • roouteelimination:

    Approximately 85 percent of cefoxitin is excreted unchanged by the kidneys over a 6-hour period, resulting in high urinary concentrations. Cefoxitin passes into pleural and joint fluids and is detectable in antibacterial concentrations in bile.

  • volumedistribution:

  • clearance: